COMMUNIQUÉS West-GlobeNewswire

SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data [...]
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
17/06/2026
- Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million of additional capacity funded at amendment closing - WALTHAM, Mass., June 17, 2026 (GLOBE NEWSWIRE) -- Dyne [...]
BrewDog Turns Up Father’s Day Across the U.K. with Gift-Ready Beer, Custom Cans and Dads Eat Free
17/06/2026
From standout beer gifts to nationwide bar experiences, BrewDog is bringing bold flavour and big Father’s Day energy to dads across the U.K. ELLON, Scotland, June 17, 2026 (GLOBE NEWSWIRE) -- Scottish brewer, BrewDog , [...]
Christian Wichert appointed Chief Executive Officer to lead next phase of growth
17/06/2026
Senior executive across industrial biotechnology and consumer markets with strong expertise in commercialization joins AMSilk as the Company advances from development through scale-up to market growth The announcement [...]
Trevi Therapeutics Announces Upcoming June and July Event Schedule
17/06/2026
NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
17/06/2026
Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease RAMAT GAN, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a [...]
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
17/06/2026
~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter of 2026 ~ LEXINGTON [...]
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
17/06/2026
Pharmaceutical executive and physician with strong experience in global research and development Over 20 years’ experience in all stages of clinical development across multiple indications, including neurology and [...]
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
17/06/2026
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development [...]
Des preuves inédites montrent comment un modèle fondé sur l’entrepreneuriat peut réduire l’extrême pauvreté parmi les réfugiés
17/06/2026
De nouvelles études montrent que le programme DREAMS augmente les revenus, l’épargne et la résilience des communautés de réfugiés en Afrique de l’Est La Fondation IKEA a engagé 7,4 millions de dollars pour financer la [...]
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
17/06/2026
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, June 17, 2026 – Kuros Biosciences (“Kuros” or the “ [...]
IBA strengthens its leadership team to support its growth
17/06/2026
Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine Vandenborre is [...]
IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend
17/06/2026
Louvain-la-Neuve, Belgium, 17 June 2026 - At its Board meeting held yesterday in Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT) welcomed two new Board members, acknowledged the departure of outgoing [...]
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data [...]
IBA renforce son Conseil d’administration avec deux nominations de premier plan et annonce la date du paiement de son dividende
17/06/2026
Louvain-la-Neuve, Belgique, le 17 juin 2026 - Lors de son Conseil d’administration tenu hier à Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT) a approuvé la nomination de nouveaux membres de son Conseil d’ [...]
IBA déploie son équipe de direction pour accompagner son développement
17/06/2026
Olivier Legrain, CEO d'IBA, est nommé Vice-Président du Conseil d'administration d'IBA et Henri de Romrée, Deputy CEO, prend la responsabilité stratégique et opérationnelle de l'ensemble des activités du Groupe. [...]
GuideAI Health Corp. Announces Closing of Business Combination, Subscription Receipt Offering, and Filing of Final Prospectus
17/06/2026
Not for distribution to U.S. Newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. BOSTON, June 16, 2026 (GLOBE [...]
Silexion Therapeutics to Attend BIO International Convention 2026
16/06/2026
Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, [...]
Shopify Announces Results of its 2026 Annual Meeting of Shareholders
16/06/2026
Internet, Everywhere, June 16, 2026 (GLOBE NEWSWIRE) -- Shopify Inc. (NASDAQ, TSX: SHOP) announced today the results of its annual meeting of shareholders held on June 16, 2026. All director nominees were elected to the [...]

Pages